So it didn't work out with Profile Biobank
_______________________________________________________________________________________________________________________________________
TERMINATION OF JOINT VENTURE AGREEMENT WITH
PROLIFE BIOBANK PTE. LTD. AND CELCOTT BIOBANK PRIVATE LIMITED
http://infopub.sgx.com/FileOpen/2017%200...eID=435917
_______________________________________________________________________________________________________________________________________
Best World - CLSA 13 Jan 2017
Poised for the big leap Well-established track record not fully appreciated Best World (BW) is a direct-selling company that has built a credible track record. Focusing on the premium skin care, it is well established outside of Singapore, and thus, the investment merits are not fully appreciated. BW’s ability to succeed in highly competitive markets like Taiwan and China is a testimony of management capabilities. Despite the share-price rally (480% over the past one year), the stock remains undervalued vs regional peers. Fundamentals are underpinned by 27% EPS Cagr over FY16-18CL and strong free cashflow and backed by ~40% net cash equity. We initiate coverage with BUY and S$2.50 target price...
(16-01-2017, 11:31 PM)opmi Wrote: [ -> ]Best World - CLSA 13 Jan 2017
Poised for the big leap Well-established track record not fully appreciated Best World (BW) is a direct-selling company that has built a credible track record. Focusing on the premium skin care, it is well established outside of Singapore, and thus, the investment merits are not fully appreciated. BW’s ability to succeed in highly competitive markets like Taiwan and China is a testimony of management capabilities. Despite the share-price rally (480% over the past one year), the stock remains undervalued vs regional peers. Fundamentals are underpinned by 27% EPS Cagr over FY16-18CL and strong free cashflow and backed by ~40% net cash equity. We initiate coverage with BUY and S$2.50 target price...
“Well-established track record not fully appreciated Best World (BW) is a direct-selling company that has built a credible track record. Focusing on the premium skin care, it is well established outside of Singapore, and thus, the investment merits are not fully appreciated.”
Can one make sense of what they are trying to say?
“Not fully appreciated” by whom?
Do they imply BWI (Best World International) is NOT well established in Singapore?
Do they imply BWI does not have a credible track record in Singapore?
Do they imply if BWI were well established in Singapore, the investment merits would be fully appreciated by (whoever they’d implied or assumed).
______________________________________________________________________________________________________________________________________
TP of $2.5! i wonder how they come up to this figure? :O :O :O
@Boon... very busy?
I saw the explanetion in CLSA Bestworld-initiation report
rgds to "not fully appreciated"
attached for your reading.
Track record not fully appreciated
Unlike many direct-selling firms, BW does not require members to make bulk
purchase, thus revenue is not inflated. This minimises risks of inventory
buildup. Importantly, BW has successfully built its product positioning in the
premium skincare segment. The success is evident through the strong
revenue growth, as the product, coupled with successful marketing strategies,
helps penetrate markets in Taiwan and China. The business model is scalable,
enjoys high operating margins, and is consistently free cashflow positive.
http://bestworld.listedcompany.com/newsr...1431784589
Another query from SGX...............
SGD 1.70 (equivalent to SGD 2.125 pre-bonus)
closing price is at all time high......................
________________________________________________________________________________________________________________________________________
Interesting response from the Company:
_______________________________________________________________________________________________________________________________________
http://infopub.sgx.com/FileOpen/2017%200...eID=436698
Question 1: Are you (the issuer) aware of any information not previously announced concerning you, your subsidiaries or associated companies which, if known, might explain the trading? Such information may include events that are potentially material and price- sensitive, such as discussions and negotiations that may lead to joint ventures, mergers, acquisitions or purchase or sale of a significant asset. You may refer to paragraph 8 in Appendix 7.1 of the Mainboard Rules for further examples.
- If yes, the information shall be announced immediately.
Company’s Response
The Company wishes to note that increased trading activity of its shares and movements to its share price are not uncommon following the release of positive research reports on the Company.
For example, the Company observed movement in the Company’s share price: - from 21 April 2016 to 8 June 2016 following the release of a positive initiation research report
by CIMB on the Company on 21 April 2016; and
- from 24 August 2016 to 6 September 2016 following the release of a positive initiation
research report by Maybank Kim Eng on 24 August 2016.
Most recently, CLSA, a brokerage and investment group headquartered in Hong Kong (www.clsa.com), released a positive initiation research report on the Company on 13 January 2017. In view of the above previous trading patterns, the Company believes that the trading activity and the movement of its share price is not unusual. At the same time, the Company wishes to remind shareholders of the Company to exercise caution when dealing with in the shares of the Company.
________________________________________________________________________________________________________________________________________________________________________________________